A set of three laws concerning the secondary use of healthcare data is making its way through the Finnish Parliament. Surprisingly, it is not clear that Parliament will ask industry leaders for their views on the proposed laws, which could jeopardize Finland’s goal of becoming the world’s leading research ecosystem.
Now that Joe Biden is U.S. President-elect, we anticipate that some of the existing business-immigration roadblocks may dissolve. Practically speaking, however, implementation of more favorable rules will take time. In addition, lockdowns and limited resources due to a new wave of Covid-19 will continue to cause immigration delays, at least for the time being.
Deb Mangone recently became Pfizer Finland’s new Country Manager. She arrived from New York City, and we interviewed her to learn what motivated her decision to come here. How does she perceive Finland’s strengths and weaknesses as a business environment and home?
Helsinki Business Hub, Pfizer Finland, and Amcham Finland brought together researchers, healthcare organizations, pharmaceutical companies, and support organizations to create new dialogue and collaboration.
Health industry investment and skilled workforce employment bring Finland tremendous economic benefit, as well as a higher standard of living for the nation’s people.
Finland is globally known for its pro-innovation policies. However, whether or not we really support innovation is often tested in the details and technicalities that, in practice, regulate and perhaps stifle innovation.
Member company Aino Health Management’s business model is to show that proactive, preventative healthcare and well-being is in the interest of HR departments and companies overall. They’ve developed tools by which data can be harnessed to help employees remain healthy and content and hence productive and engaged. In the context of global markets, companies can’t afford to lose out on this productivity.
Maturin Tchoumi, General Manager for the pharmaceutical giant Roche in Finland, is on a journey. It has taken him from his family farm in Cameroon to Tours, France for a Doctorate in Pharmaceutical Sciences; Abidjan, Cote d’Ivoire; Johannesburg, South Africa; San Francisco Bay Area, USA; and most recently Mumbai, India. He arrived in Finland eight weeks ago to fine-tune his leadership skills in a European context through another senior leadership position.
At the end of August, the Finnish government decided in its budget to fund an authority that oversees access to and use of social and health care data. Legislation
Oliver Rittgen has been a formidable powerhouse in Finland over the past six and a half years. During that time, as CEO of Bayer Nordic based out of Espoo, he’s grown the company to new heights. Bayer is now a central player in the aim to make Finland the life science hub of Europe, and much of this is due to Rittgen’s insights, determination and vision. Now, he is moving on to a new position. Congratulations!
Access your business needs with Amcham Finland in a 15-minute call.